Essential Partners’s Repligen RGEN Stock Holding History

Essential Partners’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7	Closed	-$1.15K	–	2963
2025 Q4	$1.15K	Hold	7	–	–	﹤0.01%	1985
2025 Q3	$936	Buy	+7	New	+$850	﹤0.01%	2037

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Essential Partners's RGEN Position: Q1 2026 in Review

Essential Partners sold out of Repligen (RGEN) in Q1 2026, closing a stake of 7 shares — an estimated $1.15K sold.

Essential Partners first reported a position in RGEN in Q3 2025 and held it in 2 quarters. The position peaked at $1.15K in Q4 2025. 445 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

Essential Partners reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
Essential Partners sold 7 Repligen shares in Q1 2026, an estimated $1.15K.
Essential Partners first reported a position in Repligen in Q3 2025 and held it in 2 quarters.
Essential Partners's Repligen position peaked at $1.15K in Q4 2025.
445 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Essential Partners's 13F filing for Q1 2026, filed 21 May 2026.